Dr. Ahmet Uluer is a medicine and pediatric trained pulmonologist and Director of the Adult Cystic Fibrosis Program at the combined Boston Children’s Hospital and Brigham & Women’s Hospital Adult Cystic Fibrosis Center. He is also Director of the local Therapeutic Development Network (TDN) and oversees a highly effective team of Research Coordinators and Assistants to conduct corporate sponsored and investigator-initiated clinical trials, along with two phase 2 trials as national PI. He is Co-Chair of the Protocol Review Committee of the TDN.

His clinical and research interests involve all aspects of cystic fibrosis care, including quality improvement initiatives, transitional care and outcomes research. He has been interested in complications related to acute and chronic pulmonary therapies in an aging CF population, including kidney disease and hearing loss.

Dr. Uluer completed a translational research project while earning his Master’s in Public Health degree at the Harvard TH Chan School of Public Health, looking at urinary biomarkers associated with kidney injury, as well as a prospective study of monitoring hearing loss utilizing point of care hearing assessment. He is Director of the Weitzman Family Bridges Adult Transition Program at Boston Children’s Hospital, providing age-appropriate care and transitional care support to all adult survivors with congenital or pediatric acquired chronic illness. He is working on transitional care processes and outcome measures for those with childhood-onset chronic diseases and along with other collaborators, working on building the capacity, from many perspectives, for them to be cared for in an adult medical home.